Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study: A Safety Evaluation of the Gala Airway Treatment System on Patients With Chronic Bronchitis in Canada

NCT03385616 is registered in ClinicalTrials.gov with Gala Therapeutics, Inc. as lead sponsor.

NCT NCT03385616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03385616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study: A Safety Evaluation of the Gala Airway Treatment System on Patients With Chronic Bronchitis in Canada
Lead sponsor
Gala Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 24, 2017
Completion date
February 28, 2021
Enrollment
10 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic bronchitis, copd